Prophylaxis and Therapy for Chikungunya Virus Infection | Zendy

Thérèse Couderc | Zendy; Nassirah Khandoudi | Zendy; Marc Grandadam | Zendy; Catherine Visse | Zendy; Nicolas Gangneux | Zendy; Sébastien Bagot | Zendy; JeanFrançois Prost | Zendy; Marc Lecuit | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prophylaxis and Therapy for Chikungunya Virus Infection

Author(s) -

Thérèse Couderc,

Nassirah Khandoudi,

Marc Grandadam,

Catherine Visse,

Nicolas Gangneux,

Sébastien Bagot,

JeanFrançois Prost,

Marc Lecuit

Publication year - 2009

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/600381

Subject(s) - chikungunya , arbovirus , antibody , virology , virus , outbreak , immunology , medicine , myalgia , rash

Chikungunya virus (CHIKV) is a recently reemerged arbovirus responsible for a massive outbreak of infection in the Indian Ocean region and India that has a very significant potential to spread globally because of the worldwide distribution of its mosquito vectors. CHIKV induces a usually self-limited disease in humans that is characterized by fever, arthralgia, myalgia, and rash; however, cases of severe CHIKV infection have recently been described, particularly in adults with underlying condition and neonates born to viremic mothers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research